Women suffering from irritable bowel syndrome (IBS) found something to settle their stomachs in May when the FDA cleared the way for Amitiza, a chloride channel activator that alleviates constipation, but analysts and biotechs alike contend that there's more room for competitors in the space. (BioWorld Financial Watch) Read More
